Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)

PFE 25.70

-0.1%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Anthony Wong who wrote (311)	6/14/1998 8:47:00 PM
From: Anthony Wong	Read Replies (4) of 1722

Nexmed Shares Gain as Viagra Boosts Hope for Its Similar Drug Bloomberg News June 14, 1998, 1:47 p.m. PT Robbinsville, New Jersey, June 14 (Bloomberg) -- Since Pfizer Inc's Viagra soared to popularity in mid-April, shares in Nexmed Inc., a small pharmaceutical company working on a similar anti-impotence drug, have risen 135 percent, the New Jersey Star- Ledger reported. Though Nexmed's topical creams for sexual dysfunction are in early testing stages and the company has never turned a profit, Nexmed's market capitalization is now $23 million, up from $10 million just two months ago. A Nexmed spokeswoman said the company expects the approval process for its Alprox-TD cream to take at least three years, the Star-Ledger said. Venezuela is taking steps to attack illegal sales of Viagra as demand surges with the new drug being regarded as this year's ideal Father's Day gift, according to a Venezuelan newspaper. (Star Ledger 6/14 3-1, www.njnews.com) --Deborah Stern in the Princeton newsroom (609) 279-4034/jcn

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next